Penn Medicine experts in radiology, endocrinology, endocrine surgery, medical oncology and nuclear medicine discussed the latest in safety protocols, diagnostic procedures, and management of micropapillary thyroid cancers in the context of COVID-19. The panel covers trends in de-escalation of treatment protocols for well differentiated cancers including the launch of Penn’s new evidence-based practice guideline for the management of thyroid nodules.
Related Links
Twitter @PennMDForum
Published
June 12, 2020
Created by
BROADCASTMED